Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01570972 · ClinicalTrials.gov registry record · NA
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT01570972: Completed NA study, sponsored by University of Arizona.
NCT01570972 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 103 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01570972, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
Multifamily group psychoeducation \[MFG\] and group cognitive behavioral therapy \[GCBT\] are evidence-based treatments for first episode psychosis. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect-some individuals who receive these interventions still experience a worsening of psychotic symptoms. Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could improve the clinical benefits facilitated by these two interventions.
Primary Outcome
General level of functioning to be assessed using the General Assessment of Functioning (GAF) scale
Interventions
- BEHAVIORAL Group Cognitive Behavioral Therapy
- BEHAVIORAL Multifamily Group Psychoeducation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2010-02 |
| Est. Completion | 2017-04 |
| Phase | NA |
What the finished NCT01570972 record still lists
NCT01570972 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Group Cognitive Behavioral Therapy is the first listed.
NCT01570972 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01570972 about?
NCT01570972 is a clinical study titled "Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis". Multifamily group psychoeducation \[MFG\] and group cognitive behavioral therapy \[GCBT\] are evidence-based treatments for first episode psychosis. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect-some individuals who receive these interventions still experienc...
What is the current status of trial NCT01570972?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2010-02. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01570972?
The interventions under investigation include: Group Cognitive Behavioral Therapy (BEHAVIORAL), Multifamily Group Psychoeducation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01570972?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01570972's enrollment target sits among peer trials
103 837th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia